GPT and metabolic dysfunction-associated steatotic liver disease: Similarly, de Luis et al. [87] demonstrated an improvement in anthropometric measurements, blood pressure, homeostasis model assessment-insulin resistance (HOMA-IR), TG, low-density lipoprotein (LDL), total cholesterol (TC), and liver enzymes (ALT, AST, and GGT) in NAFLD patients under low-fat or low-CHO dietsregardless of which macronutrients they emphasized.